OBJECTIVES: The aim of this investigation was to explore the feasibility of various nanocarriers to enhance progesterone penetration via the human abdominal skin. METHODS: Four progesterone-loaded nanocarriers; cubosomes, nanoliposomes, nanoemulsions and nanomicelles were formulated and characterized regarding particle size, zeta potential, % drug encapsulation and in vitro release. Structural elucidation of each nanoplatform was performed using transmission electron microscopy. Ex vivo skin permeation, deposition ability and histopathological examination were evaluated using Franz diffusion cells. RESULTS: Each nanocarrier was fabricated with a negative surface, nanometric size (≤ 270 nm), narrow size distribution and reasonable encapsulation efficiency. In vitro progesterone release showed a sustained release pattern for 24 h following a non-Fickian transport diffusion mechanism. All nanocarriers exhibited higher transdermal flux relative to free progesterone. Cubosomes revealed a higher skin penetration with transdermal steady flux of 48.57.10(-2) ± 0.7 µg/cm(2) h. Nanoliposomes offered a higher percentage of skin progesterone deposition compared to other nanocarriers. Based on the histopathological examination, cubosomes and nanoliposomes were found to be biocompatible for transdermal application. Confocal laser scanning microscopy confirmed the ability of fluoro-labeled cubosomes to penetrate through the whole skin layers. CONCLUSION: The elaborated cubosomes proved to be a promising non-invasive nanocarrier for transdermal hormonal delivery.
OBJECTIVES: The aim of this investigation was to explore the feasibility of various nanocarriers to enhance progesterone penetration via the human abdominal skin. METHODS: Four progesterone-loaded nanocarriers; cubosomes, nanoliposomes, nanoemulsions and nanomicelles were formulated and characterized regarding particle size, zeta potential, % drug encapsulation and in vitro release. Structural elucidation of each nanoplatform was performed using transmission electron microscopy. Ex vivo skin permeation, deposition ability and histopathological examination were evaluated using Franz diffusion cells. RESULTS: Each nanocarrier was fabricated with a negative surface, nanometric size (≤ 270 nm), narrow size distribution and reasonable encapsulation efficiency. In vitro progesterone release showed a sustained release pattern for 24 h following a non-Fickian transport diffusion mechanism. All nanocarriers exhibited higher transdermal flux relative to free progesterone. Cubosomes revealed a higher skin penetration with transdermal steady flux of 48.57.10(-2) ± 0.7 µg/cm(2) h. Nanoliposomes offered a higher percentage of skin progesterone deposition compared to other nanocarriers. Based on the histopathological examination, cubosomes and nanoliposomes were found to be biocompatible for transdermal application. Confocal laser scanning microscopy confirmed the ability of fluoro-labeled cubosomes to penetrate through the whole skin layers. CONCLUSION: The elaborated cubosomes proved to be a promising non-invasive nanocarrier for transdermal hormonal delivery.
Entities:
Keywords:
Nanocarriers; cubosomes; human skin; progesterone; transdermal permeation
Authors: Luis Eduardo Mosquera Narvaez; Lindalva Maria de Meneses Costa Ferreira; Suellen Sanches; Desireé Alesa Gyles; José Otávio Carréra Silva-Júnior; Roseane Maria Ribeiro Costa Journal: Molecules Date: 2022-04-24 Impact factor: 4.927
Authors: Noha Khalifa Abo Aasy; Doaa Ragab; Marwa Ahmed Sallam; Doaa A Abdelmonsif; Rania G Aly; Kadria A Elkhodairy Journal: Int J Nanomedicine Date: 2019-09-17
Authors: Essam M Eissa; Mohammed H Elkomy; Hussein M Eid; Adel A Ali; Mohammed A S Abourehab; Amal M Alsubaiyel; Ibrahim A Naguib; Izzeddin Alsalahat; Amira H Hassan Journal: Pharmaceutics Date: 2022-06-29 Impact factor: 6.525